We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Filters

Equity Crowdfunding Pitches

Showing results
Wi-Fi Securities Limited is a cyber security company that aims to revolutionise the security of public access Wi-Fi. To realise this vision, the company is developing a unique patent-protected system called SpriteGuard™ which will protect you and your data from hackers by stopping you connecting to fake hotspots. The system is targeted towards the $550 bn worldwide hospitality industry and has the ability to expand to other large global markets like city-wide free Wi-Fi, airports and coffee shops. Moreover, Wi-Fi Securities Limited has a highly experienced Wi-Fi Securities management board that has a track record of delivering multi-million-pound projects from concept to successful commercial deployment.

Pitch Rated

77%

Overall

rating powered by

CROWD RATING™

days to go: Extended investment: £1,014,708
Medic Bleep is a simple, secure and innovative patient-focused solution to communication challenges that healthcare professionals and the wider team in the UK National Health Service (NHS) face while going about their everyday work. It is saving each nurse & each junior doctor an estimated 48 minutes per shift. This coincides with the UK's Department of Health calling for a ban on pagers. If implemented across the NHS, it could free up the time to care for an estimated 11,000 nurses. To ensure data privacy and safety, the company allows communication to occur via the app. As a result of these safeguards and its user-friendly portal, the company's app has been downloaded 16,000 times by UK doctors and nurses. With the funds raised, the company will aim to solve looming technology gaps for over 30% of the NHS in the next 3 years and expand globally.

Pitch Rated

83%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £814,600
Graphene Composites is a nano-materials technology company that creates the strongest, lightest, most resilient material by combining aerogel, graphene, and other nano-materials. Founded in 2016, the company, in partnerships with US/Global defence/aerospace contractor, is one of the few graphene nanotechnology companies who are developing bulletproof graphene/aerogel armour. Moreover, it is also extending its GC Shield technology to military/police applications. Besides these, GC's technology can also be used to improve the strength and reliability of wind turbines.

Pitch Rated

55%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £597,360
The Noo aims to redefine the delivery space by facilitating the delivery of anything, anywhere, anytime from a single application. It argues that between February-April 2020, online food delivery weekly sales skyrocketed by 840% amidst a boom in e-commerce sales. The Noo points out that with every innovation in the name of convenience, people seem to expect more. It intends to deliver just that through its community platform allowing anyone to request anything at a price set by the requestor and finally, facilitate earning by simply owning a smartphone. The company also aspires to create a space where the local high street can compete with today's delivery giants. It will use the investment to enhance and launch its app, fund marketing campaigns, hire key personnel, and make The Noo visible across more cities.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £149,388
EMERGEiQ is a cloud-based platform targeted towards Small and Medium Enterprises (SMEs) and large corporate organisations. The company plans on having an extensive suite of algorithms that simplifies Data Science (DS) and Artificial Intelligence (AI) at low cost, across all sectors. EMERGEiQ asserts that its analytics can help businesses improve operational productivity, cut costs, and eventually generate more revenue. It has worked with companies across a variety of sectors such as finance, medicine, stock market, and insurance. The company will use will 30% of the investment for R&D, 25% to purchase software and hardware to improve platform capabilities, 25% to market its new product line, 10% as working capital, and 10% as miscellaneous expenses.

Pitch Rated

71%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £150,000
Invisage is a cloud-based platform that helps asset managers optimise their performance and research costs by identifying the true value of investment research. The company asserts that Directive 2014/65/EU has led to the investment research market falling from $16.5 billion to $14 billion as managers look to reduce costs and increase value. Invisage asserts that its platform helps asset managers identify, objectively measure ‘value’ added by research, and consume only high-impact research. The company also offers a web-based research consolidation, valuation and attribution solution that gives a quantitative assessment of value added by research to client portfolios. Invisage will use the investment to enhance deep learning-based Natural Language Processing (NLP) models that detect the implicit ideas from research narrative, build partnerships with data providers and other solution providers, and market scale its sales function

Pitch Rated

80%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £75,000
Percuro is a low carbon, next-generation pet food that is ethically farmed and formulated using insect proteins. The company argues that its pet food has a low carbon pawprint whilst being hypoallergenic and nutritious with low inflammation properties. Percuro has launched its Direct-To-Consumer (DTC) site in the UK and Germany with a roll-out plan that includes covering additional EU markets later in 2021, raised a £340,000 seed investment in the previous 10 months, and signed product listing agreements with key retailers in the UK and Singapore. The company will use 40% of the investment for brand building through digital marketing, 30% for retailer brand-building investments, 20% towards launching treats and its plant dog range, and 10% towards new market expansion into Asia.

Pitch Rated

47%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £618,596
MedicSpot is a healthcare company that is aiming to revolutionise healthcare delivery by combining the advantages of online and offline care. The company provides patients at designated hospitals with diagnostic tools like a stethoscope, oximeter, blood pressure monitor and thermometer which, in turn, is connected to the MedicSpot network. Onboard General Physicians (GPs) engage in live sessions with patients, guide them on how to use the tools, and perform a variety of diagnoses like listening to a patient’s heart and lungs, looking down their throat and into their ears, taking their blood pressure and oxygen readings, and measuring their body temperature. The company is also expanding into another subsidiary, Arc Health, which it claims will perform the aforementioned tasks with more efficiency and accuracy. The company will use the investment to increase the number of Medicspot clinics to 1,000, gain further NHS market share, launch a corporate business model and allow international pilots to take place.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,048,396
Lemonade Dolls (LD) is the UK's first subscription underwear brand that aims to make hassle-free and comfortable underwear for young women. The company's revenue has grown 550% since January 2020. The Lemonade Dolls brand is sold in Topshop, New Look, and ASOS Marketplace. LD has 2,600 subscribers, 15,000 Dolls on its database, and over 70,000 followers across LD and Lemon's on Instagram. It also aims to bring audiences different brands like Candy Kittens, Frank Body, Dr Paw Paw, Mooncup, and Oh K!. The company has been praised by fashion magazine Grazia as having 'Broken the mould'. The company will use the investment to develop the technology behind its subscription platform, grow its product offering, strengthen its virtual presence, and drive brand awareness.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £258,328
EnXray are developing Low Energy X-ray (LEXR) technologies to sterilise equipment in commercial or research settings where low volume/high value therapeutic products, such as cancer vaccines and stem cell implants are being developed. Their aim is to reduce the need for third party providers and have the sterilisation process done on-site and on-demand with simple and safe equipment to reduce cost and save time for medical research organisations.

Pitch Rated

61%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £376,230
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph